Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000015402
- Lead Sponsor
- Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Serious infection 2.Serious liver and/or kidney disease 3.End stage renal disease with undergoing hemodialysis or peritoneal dialysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c, fasting plasma glucose, insulin, body weight, fat mass, lean body mass, food consumption
- Secondary Outcome Measures
Name Time Method serum osmolality, urine osmolality, blood urea nitrogen, serum creatinine, LDL cholesterol, HDL cholesterol, triglyceride, free fatty acid, GOT, GPT, glucagon, GLP-1